Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. September 2024 07:00 ET | Quelle: Pharmazz, Inc.

Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President

Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President.
22. März 2024 07:00 ET | Quelle: Pharmazz, Inc.

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin®) as a resuscitative agent
20. März 2023 07:30 ET | Quelle: Pharmazz, Inc.

Pharmazz Inc. Announces Key Publications Regarding the Role of Adrenergic Receptors in Venous Blood Return to Treat Shock

Centhaquine (Lyfaquin®) is an adrenergic agent that increases cardiac preload by activating alpha2B adrenergic receptors to increase venous blood return to the heart and decreases cardiac afterload by...